Connect with us

Health

Black fungus: this company announced to launch indigenous medicine against infection, read the full story

The company has claimed that their drug has been approved by the Controller General of Indian Medicine (DCGI)

Published

on

Photo from Unplash
Photo from Unplash

The problem of ‘black fungus’ along with the corona pandemic in the country has doubled the challenge of the health system. Central and state governments are making efforts at their own level to deal with ‘black fungus’ means mucormycosis. The central government has gathered to increase the availability of Amphotericin-B, an important drug used in the treatment of black fungus. Apart from this, a domestic company has announced the launch of a new drug to fight ‘black fungus’.

According to a leading daily report, Hyderabad-based MSN Laboratories has announced the launch of ‘Posaconazole’ in the Indian market. The company has announced to offer it as 100mg delayed-release tablet and 300mg injection. The company has also claimed that their drug has been approved by the Controller General of Indian Medicine (DCGI).

Photo from Unplash

Photo from Unplash

According to the report, information has been given by the government that the supply of Amphotericin-B drug in the country was limited. But now its supply is being increased continuously. To increase availability of Amphotericin-B drug, the government has already allowed five more companies to produce it. Also, the existing manufacturing companies are also increasing their production capacity.

So far, a total of 5,424 cases of ‘black fungus’ have been reported in the country. Union Health Minister Dr. Harsh Vardhan has given this information. He has reported that 55 percent of Black Fungus patients also had diabetes. Explain that black fungus is spread in people from soil, plants, spoiled fruits and vegetables. However, there are very few cases of getting infected from it.

WP Twitter Auto Publish Powered By : XYZScripts.com